Financials CardioComm Solutions, Inc. OTC Markets

Equities

EKGGF

CA14159N2086

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 14:54:11 02/05/2024 BST 5-day change 1st Jan Change
0.0038 USD -47.95% Intraday chart for CardioComm Solutions, Inc. 0.00% -62.00%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5.498 4.921 7.782 4.51 3.773 1.512
Enterprise Value (EV) 1 5.958 5.376 7.966 4.84 4.061 1.91
P/E ratio -9.51 x -4.6 x -122 x 30,000 x -1,563 x -15.6 x
Yield - - - - - -
Capitalization / Revenue 5.11 x 5.63 x 9.32 x 6.61 x 3.79 x 1.72 x
EV / Revenue 5.54 x 6.15 x 9.54 x 7.09 x 4.08 x 2.18 x
EV / EBITDA -13.4 x -6.68 x -559 x -29.6 x -233 x -14 x
EV / FCF 117 x 13.5 x 2,372 x -11.2 x 265 x -42.1 x
FCF Yield 0.86% 7.43% 0.04% -8.96% 0.38% -2.38%
Price to Book -80.5 x -5.48 x -11.6 x -10.7 x -9.26 x -3 x
Nbr of stocks (in thousands) 137,440 140,614 141,490 150,343 150,915 151,165
Reference price 2 0.0400 0.0350 0.0550 0.0300 0.0250 0.0100
Announcement Date 30/04/19 15/06/20 30/04/21 02/05/22 03/08/23 30/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1.076 0.8749 0.8348 0.6825 0.9958 0.8764
EBITDA 1 -0.4442 -0.8046 -0.0143 -0.1636 -0.0174 -0.1365
EBIT 1 -0.4454 -0.8072 -0.0182 -0.1681 -0.0225 -0.1401
Operating Margin -41.41% -92.27% -2.18% -24.63% -2.26% -15.99%
Earnings before Tax (EBT) 1 -0.5771 -1.062 -0.0636 0.000283 -0.002455 -0.0973
Net income 1 -0.5771 -1.062 -0.0636 0.000283 -0.002455 -0.0973
Net margin -53.65% -121.4% -7.62% 0.04% -0.25% -11.11%
EPS 2 -0.004205 -0.007612 -0.000449 0.000001 -0.000016 -0.000643
Free Cash Flow 1 0.0511 0.3996 0.003359 -0.4334 0.0153 -0.0454
FCF margin 4.75% 45.67% 0.4% -63.51% 1.54% -5.18%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 30/04/19 15/06/20 30/04/21 02/05/22 03/08/23 30/04/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.46 0.45 0.18 0.33 0.29 0.4
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -1.036 x -0.5655 x -12.93 x -2.015 x -16.56 x -2.919 x
Free Cash Flow 1 0.05 0.4 0 -0.43 0.02 -0.05
ROE (net income / shareholders' equity) -274% 220% 8.12% -0.05% 0.59% 21.3%
ROA (Net income/ Total Assets) -21.2% -71.4% -3.33% -24.8% -3.67% -28.2%
Assets 1 2.725 1.488 1.91 -0.001141 0.0669 0.3454
Book Value Per Share 2 -0 -0.0100 -0 -0 -0 -0
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 0 0.01 0.01 - 0 0
Capex / Sales 0.23% 0.67% 1.6% - 0.22% 0.23%
Announcement Date 30/04/19 15/06/20 30/04/21 02/05/22 03/08/23 30/04/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. EKG Stock
  4. EKGGF Stock
  5. Financials CardioComm Solutions, Inc.